A Plus Biotechnology , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow15.21%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, 6918.TWO shows a ROE of 15.21%. That is above the sector sector average of 11.64%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about 11.64%. A Plus Biotechnology , Ltd. is at 15.21%, which is higher that average. That is roughly 30.7% above the sector mean. Use the comparison chart on this page to see how 6918.TWO stacks up against individual peers as well.
Check the historical chart to see whether 6918.TWO's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare A Plus Biotechnology , Ltd. with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has A Plus Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 15.21%) with ownership activity and broader fundamentals.
